ロード中...
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies
Numerous antiangiogenic agents are approved for the treatment of oncological diseases. However, almost all patients develop evasive resistance mechanisms against antiangiogenic therapies. Currently no predictive biomarker for therapy resistance or response has been established. Therefore, the aim of...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4991441/ https://ncbi.nlm.nih.gov/pubmed/26956051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7915 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|